Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »
Reset 

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024

GV20 Therapeutics Announces Clinical Trial Collaboration to Evaluate GV20-0251, a First-in-Class Antagonist Antibody Against the Novel Immune Checkpoint IGSF8, in Combination with KEYTRUDA® (pembrolizumab)

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  GV20 Therapeutics

Two Independent Studies Representing Largest Real-World Experience with Hypothermic Oxygenated Machine Perfusion (HOPE) Reinforce Significant Benefits in Liver Preservation Before Transplantation, according to Bridge to Life Ltd.

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024

SCOUT RECEIVES FUNDING FROM CARB-X TO DEVELOP A LOW-COST POINT-OF-CARE AND HOME DIAGNOSTIC FOR GONORRHEA AND CHLAMYDIA

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Scout Bio, Inc. | Scout Ventures

Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Blueprint Medicines Corporation

BioLife Solutions Announces the Divestiture of its Stirling Freezer Business

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  BioLife Solutions, Inc.

Angel Aligner Launches in Canada with Innovative Aligner Technology Built on 20+ Years of Experience and 1+ Million Smiles

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Anixa Biosciences, Inc.

Organizations power American Red Cross response where the need is greatest

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  American Red Cross Holland Laboratory

Initial Therapeutics Names Peter DiLaura as CEO

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Initial Therapeutics, Inc.

European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Moleculin Biotech, Inc.

NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024

Natural Shrimp, Inc. Completes Successful Trial in Japan

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024

Soligenix Announces Pricing of $4.75 Million Public Offering

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Soligenix, Inc.

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  NRx Pharmaceuticals, Inc.

Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  DarioHealth Corp.

Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  AbbVie Inc.

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  NRx Pharmaceuticals, Inc.

Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Evofem Biosciences, Inc.

Rock Creek Foundation Celebrates 50th Anniversary with Gala Event

Read more ››
By: PR Newswire Association LLC. - 18 Apr 2024
Related companies:  Rock Creek Capital
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »
to the top ↑